ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1947

Muscle Wasting in HTNFtg Mice, an Animal Model for Rheumatoid Arthritis, Due to Increased Cathepsin L and LC3B Expression

Martin Willburger1, Birgit Niederreiter1, Ewald Unger2, Josef S. Smolen3, Kurt Redlich1 and Silvia Hayer1, 1Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Center for Medical Physics and Biomedicla Engineering, Medical University of Vienna, Vienna, Austria, 3Division of Rheumatology, Department of Internal Medicine III,, Medical University of Vienna and Hietzing Hospital, Vienna, Austria

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: animal models and tumor necrosis factor (TNF), Muscle strength, musculoskeletal disorders, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Muscle Biology, Myositis and Myopathies: Genetics, Autoantibodies and other Molecular Aspects of Idiopathic Inflammatory Myopathies and Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: To investigate the impact of systemic inflammation on skeletal muscles in human tumor necrosis factor transgenic (hTNFtg) animals.

Methods: We isolated triceps surae, quadriceps, tibialis anterior as well as rectus abdominis muscles from hTNFtg animals at different time-points of disease starting at week 4 after birth. Muscle weight and body weight were assessed from these animals. Age and sex-matched wildtype (wt) animals served as controls. We performed quantitative real-time PCR for Cathepsin L, B, S, H, D, LC3-B, MMP-9 and Interleukin (IL)-1 and IL-6 from mRNA isolated from muscle tissues of hTNFtg and wt animals. Moreover, hTNFtg animals were treated for 5 weeks with anti-TNF ab (Infliximab, 10mg/kg, 3x per week, i.p.) starting either at week 6 or week 10 after birth. Muscle tissue sections were also stained for macrophages, neutrophils, T cells and B cells. Mobility of animals was assessed by video-analysis using Ethovision Software (from Noldus, The Netherlands). Functionality of triceps surae muscle was evaluated by electro-stimulation.

Results: We could demonstrate that hTNFtg mice significantly lost muscle weight when compared to sex- and age matched wt animals. Reductions in muscle weight became already manifest at early stages of the disease, at week 4, and continuously progressed until week 16. Bodyweight was also significantly lower in hTNFtg animals compared to their wt littermates. Next, we found significantly increased mRNA expression levels of Cathepsin L, a lysosomal endopeptidase responsible for muscle protein degradation, in muscles from hTNFtg compared to their wt littermates. In contrast, other proteases such as cathepsin B, S, H, D did not significantly increased differ. In addition, we also found LC3B, an enzyme for autophagy-lysosome-mediated proteolysis, to be upregulated in hTNFtg mice compared to wt animals. Moreover, proinflammatory cytokines such as IL-1 and IL-6 were also significantly upregulated in muscles from hTNFtg mice. Interestingly, we observed an increased presence of macrophages and granulocytes in the muscle vascular system but no accumulation of inflammatory cells into the muscle tissue. We also investigated the rectus abdominis muscle, which is not located between inflamed articular joints, and found elevated levels of Cathepsin L and LC3B in this muscle, indicating that hTNFtg mice suffer from a systemic muscle proteolysis due to systemic inflammation. In addition, functionality of muscles was impaired as observed by markedly reduced maximal strength and faster fatigue in triceps surae from hTNFtg mice compared to wt animals. Remarkably, mobility of hTNFtg animals was already significantly reduced at week 6 indicating reduced use of muscles at early stage of TNF driven disease. TNF blockade at both early and late time points could completely rescue mobility to wildtype levels, whereas muscle atrophy could not be prevented by treatment at late stage of arthritis.

Conclusion: Despite spontaneous development of chronic inflamed, erosive arthritis, chronic overexpression of TNF leads to skeletal muscle atrophy due to increased tissue-degrading cathepsin L and LC3B and reduced mobility starting at early phase of arthritis disease in hTNFtg animals.


Disclosure:

M. Willburger,
None;

B. Niederreiter,
None;

E. Unger,
None;

J. S. Smolen,
None;

K. Redlich,
None;

S. Hayer,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/muscle-wasting-in-htnftg-mice-an-animal-model-for-rheumatoid-arthritis-due-to-increased-cathepsin-l-and-lc3b-expression/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology